Ad is loading...
RLBGX
Price
$36.17
Change
-$0.32 (-0.88%)
Updated
Nov 15 closing price
RLEFX
Price
$36.11
Change
-$0.33 (-0.91%)
Updated
Nov 15 closing price
Ad is loading...

RLBGX vs RLEFX

Header iconRLBGX vs RLEFX Comparison
Open Charts RLBGX vs RLEFXBanner chart's image
American Funds American Balanced R6
Price$36.17
Change-$0.32 (-0.88%)
VolumeN/A
CapitalizationN/A
American Funds American Balanced R5E
Price$36.11
Change-$0.33 (-0.91%)
VolumeN/A
CapitalizationN/A
RLBGX vs RLEFX Comparison Chart
Loading...
View a ticker or compare two or three
VS
RLBGX vs. RLEFX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RLBGX is a StrongBuy and RLEFX is a StrongBuy.

FUNDAMENTALS
Fundamentals
RLBGX (236B) and RLEFX (236B) have equal amount of cash in the bank . RLBGX pays higher dividends than RLEFX: RLBGX (2.55) vs RLEFX (2.42). RLBGX was incepted earlier than RLEFX: RLBGX (16 years) vs RLEFX (9 years). RLBGX (171.00) and RLEFX (171.00) have comparable annual turnover. RLBGX (250) and RLEFX (250) have matching initial minimum investment requirements. RLBGX (21.31) and RLEFX (21.09) have marching annual gain over last year. RLBGX (36.78) and RLEFX (35.95) have equivalent 5 years return.
RLBGXRLEFXRLBGX / RLEFX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence16 years9 years-
Gain YTD14.38514.211101%
Front LoadN/AN/A-
Min. Initial Investment250250100%
Min. Initial Investment IRAN/AN/A-
Net Assets236B236B100%
Annual Yield % from dividends2.552.42106%
Returns for 1 year21.3121.09101%
Returns for 3 years11.3010.95103%
Returns for 5 years36.7835.95102%
Returns for 10 years53.54N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SKYW111.330.52
+0.47%
SkyWest
TCBK47.59-0.02
-0.04%
TriCo Bancshares
WIT6.72-0.07
-1.03%
Wipro Limited
EDAP2.45-0.07
-2.78%
EDAP TMS SA
ELEV0.53-0.05
-8.41%
Elevation Oncology